Clinical Trials for HR Low-Positive/HER2-Negative Breast Neoplasms

Find clinical trials for hr low-positive/her2-negative breast neoplasms. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT ID: NCT06966700

This clinical trial is studying a new treatment called sacituzumab tirumotecan (or sac-TMT) for people with certain types of breast cancer, specifically high-risk, early-stage triple-negative breas...

Not yet recruiting

Phase: PHASE3 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions